Skip to content
Search

Latest Stories

Lord Darzi's NHS investigation: IRP submits evidence, highlights shift in reconfiguration trends

Lord Darzi's NHS investigation: IRP submits evidence, highlights shift in reconfiguration trends

Professor Sir Norman Williams, Chair of the IRP, informs Lord Darzi's independent investigation that recent NHS reconfigurations are driven by operational challenges rather than a focus on improving clinical outcomes

The Independent Reconfiguration Panel (IRP) has submitted evidence to Lord Darzi's independent investigation into NHS performance.


The IRP, accountable to the Secretary of State, primarily advises ministers on reconfigurations and changes to NHS services in England. Additionally, they offer informal advice to any parties involved in NHS service changes to help improve policy and practice.

Lord Darzi's 2008 report, Leading Local Change, part of the wider NHS Next Stage Review, stressed that NHS reconfigurations should be clinically driven, locally led, and focused on benefiting patients.

In a letter to Lord Darzi, Professor Sir Norman Williams, Chair of the IRP, acknowledged the NHS has significantly improved in this area, particularly in its approach to involving the public and patients, including using the regional Clinical Senates to support and assure local work.

However, in recent times, there has been a change in the trend due to the significant performance challenges faced by the NHS.

The IRP has observed that “rather than service change being driven by an ambition to improve clinical outcomes, the trend has often been for reconfigurations to emerge from operational necessity such as a lack of NHS staffing to sustain services, as well as the poor condition of NHS estates.”

This issue is particularly evident in the community hospitals, Professor Williams stated in the letter.

Over the past 20 years, the most common type of NHS reconfiguration referred to the IRP has been the major reorganisation of acute hospital care, such as the centralisation of emergency and elective care on separate ‘hot’ and ‘cold’ hospital sites.

Professor Williams noted that these proposals frequently result in the 'downgrade' of a hospital site, replacing the emergency department with an urgent treatment centre, which understandably becomes an emotional and contentious issue for the local community.

The IRP is also concerned about services that were temporarily closed or reconfigured due to staffing issues during the Covid-19 pandemic but remain so years later.

Professor Williams pointed out that these 'temporary reconfigurations' are common in urgent treatment centres and freestanding midwifery-led birth units, restricting access to care and raising concerns about their long-term sustainability.

“The continuing uncertainty around the future of these services is unfair to patients and the NHS staff who work in them,” he said.

Professor Williams stressed the importance of NHS integrated care boards regularly reviewing these ongoing temporary changes and developing long-term plans in collaboration with local system partners and the public.

The IRP has welcomed the new powers introduced via the Health and Care Act 2022, which allow the Secretary of State to intervene in NHS reconfigurations by 'calling in' proposals for a decision and acting as the final arbiter.

“The new legislation presents an opportunity for ministers to take decisions on NHS reconfigurations in a timely manner and ensure progress is made when options for local resolution have been exhausted,” Professor Williams said.

He emphasised that a decision by the Secretary of State to 'call in' a proposal should be seen as a neutral act, allowing ministers to examine concerns raised by stakeholders using a fair process.

Additionally, Professor Williams believes there is potential to streamline the approval process for major capital schemes involving the reconfiguration of NHS services.

The IRP also stresses that NHS reconfiguration proposals should include a meaningful impact assessment that addresses both health and healthcare inequalities.

“Wider factors such as socio-economic deprivation, healthy life expectancy and changes in population demographics can also often be overlooked in NHS reconfiguration planning and need to be considered using a system wide approach,” Professor Williams suggested.

In July, Health Secretary, Wes Streeting, ordered this independent investigation aimed at uncovering the “hard truths” about the “broken” NHS.

The findings from this investigation, which is expected to be completed by September, will provide the basis for the government’s 10-year plan to reform the NHS.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less